Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids
- 1 October 2003
- journal article
- review article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 91 (4) , 326-334
- https://doi.org/10.1016/s1081-1206(10)61677-8
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available dataAnnals of Allergy, Asthma & Immunology, 2002
- Inhaled Mometasone FuroateDrugs, 2001
- 605 Fatty acid ester formation appears to increase and prolong the retention of budesonide in human nasal mucosa in vivo as compared with fluticasone propionateJournal of Allergy and Clinical Immunology, 2000
- Importance of drug-device interaction in determining systemic effects of inhaled cor ticosteroidsThe Lancet, 1999
- Adrenal Effects and Pharmacokinetics of CFC-free Beclomethasone Dipropionate: a 14-Day Dose-Response StudyJournal of Pharmacy and Pharmacology, 1999
- Dose Response to Inhaled Corticosteroids: Benefits and RisksSeminars in Respiratory and Critical Care Medicine, 1998
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997
- Anti-Inflammatory Properties of Fluticasone PropionateInternational Archives of Allergy and Immunology, 1995
- Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDIEuropean Respiratory Journal, 1994
- Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assayArchives of Dermatology, 1970